93 related articles for article (PubMed ID: 9240538)
1. Prostate cancer: relative effects of demographic, clinical, histologic, and MR imaging variables on the accuracy of staging.
Getty DJ; Seltzer SE; Tempany CM; Pickett RM; Swets JA; McNeil BJ
Radiology; 1997 Aug; 204(2):471-9. PubMed ID: 9240538
[TBL] [Abstract][Full Text] [Related]
2. Preoperative neural network using combined magnetic resonance imaging variables, prostate-specific antigen, and Gleason score to predict positive surgical margins.
Poulakis V; Witzsch U; de Vries R; Emmerlich V; Meves M; Altmannsberger HM; Becht E
Urology; 2004 Sep; 64(3):516-21. PubMed ID: 15351582
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of prebiopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer.
Vilanova JC; Barceló-Vidal C; Comet J; Boada M; Barceló J; Ferrer J; Albanell J
AJR Am J Roentgenol; 2011 Jun; 196(6):W715-22. PubMed ID: 21606259
[TBL] [Abstract][Full Text] [Related]
4. [Staging of prostate cancer: value of the combined information of endorectal MRI, biopsy Gleason score, and preoperative PSA level].
Wetter A; Ajdukovic AN; Fliessbach K; Lehnert T; Engl T; Jacobi V; Vogl TJ
Rofo; 2006 Apr; 178(4):385-90. PubMed ID: 16607587
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer: incremental value of endorectal MR imaging findings for prediction of extracapsular extension.
Wang L; Mullerad M; Chen HN; Eberhardt SC; Kattan MW; Scardino PT; Hricak H
Radiology; 2004 Jul; 232(1):133-9. PubMed ID: 15166321
[TBL] [Abstract][Full Text] [Related]
6. Staging prostate cancer with MR imaging: a combined radiologist-computer system.
Seltzer SE; Getty DJ; Tempany CM; Pickett RM; Schnall MD; McNeil BJ; Swets JA
Radiology; 1997 Jan; 202(1):219-26. PubMed ID: 8988214
[TBL] [Abstract][Full Text] [Related]
7. The potential role of prebiopsy magnetic resonance imaging combined with prostate-specific antigen density in the detection of prostate cancer.
Kubota Y; Kamei S; Nakano M; Ehara H; Deguchi T; Tanaka O
Int J Urol; 2008 Apr; 15(4):322-6; discussion 327. PubMed ID: 18380820
[TBL] [Abstract][Full Text] [Related]
8. Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy.
Sciarra A; Panebianco V; Cattarino S; Busetto GM; De Berardinis E; Ciccariello M; Gentile V; Salciccia S
BJU Int; 2012 Dec; 110(11):1661-5. PubMed ID: 22564540
[TBL] [Abstract][Full Text] [Related]
9. Preoperative neural network using combined magnetic resonance imaging variables, prostate specific antigen, and Gleason score to predict prostate cancer recurrence after radical prostatectomy.
Poulakis V; Witzsch U; de Vries R; Emmerlich V; Meves M; Altmannsberger HM; Becht E
Eur Urol; 2004 Nov; 46(5):571-8. PubMed ID: 15474265
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer: body-array versus endorectal coil MR imaging at 3 T--comparison of image quality, localization, and staging performance.
Heijmink SW; Fütterer JJ; Hambrock T; Takahashi S; Scheenen TW; Huisman HJ; Hulsbergen-Van de Kaa CA; Knipscheer BC; Kiemeney LA; Witjes JA; Barentsz JO
Radiology; 2007 Jul; 244(1):184-95. PubMed ID: 17495178
[TBL] [Abstract][Full Text] [Related]
11. Hormonal ablation of prostatic cancer: effects on prostate morphology, tumor detection, and staging by endorectal coil MR imaging.
Chen M; Hricak H; Kalbhen CL; Kurhanewicz J; Vigneron DB; Weiss JM; Carroll PR
AJR Am J Roentgenol; 1996 May; 166(5):1157-63. PubMed ID: 8615261
[TBL] [Abstract][Full Text] [Related]
12. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of prostate cancer in patients with persistently elevated PSA and tumor-negative biopsy in ambulatory care: performance of MR imaging in a multi-reader environment.
Scheidler J; Weöres I; Brinkschmidt C; Zeitler H; Panzer S; Scharf M; Heuck A; Siebels M
Rofo; 2012 Feb; 184(2):130-5. PubMed ID: 22274854
[TBL] [Abstract][Full Text] [Related]
14. Combined endorectal and phased-array MRI in the prediction of pelvic lymph node metastasis in prostate cancer.
Wang L; Hricak H; Kattan MW; Schwartz LH; Eberhardt SC; Chen HN; Scardino PT
AJR Am J Roentgenol; 2006 Mar; 186(3):743-8. PubMed ID: 16498101
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging.
Fütterer JJ; Heijmink SW; Scheenen TW; Veltman J; Huisman HJ; Vos P; Hulsbergen-Van de Kaa CA; Witjes JA; Krabbe PF; Heerschap A; Barentsz JO
Radiology; 2006 Nov; 241(2):449-58. PubMed ID: 16966484
[TBL] [Abstract][Full Text] [Related]
16. Staging of prostate cancer: results of Radiology Diagnostic Oncology Group project comparison of three MR imaging techniques.
Tempany CM; Zhou X; Zerhouni EA; Rifkin MD; Quint LE; Piccoli CW; Ellis JH; McNeil BJ
Radiology; 1994 Jul; 192(1):47-54. PubMed ID: 8208963
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of prostate cancer in patients with an elevated prostate-specific antigen level: role of endorectal MRI and MR spectroscopic imaging.
Costouros NG; Coakley FV; Westphalen AC; Qayyum A; Yeh BM; Joe BN; Kurhanewicz J
AJR Am J Roentgenol; 2007 Mar; 188(3):812-6. PubMed ID: 17312072
[TBL] [Abstract][Full Text] [Related]
18. The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis.
Shukla-Dave A; Hricak H; Kattan MW; Pucar D; Kuroiwa K; Chen HN; Spector J; Koutcher JA; Zakian KL; Scardino PT
BJU Int; 2007 Apr; 99(4):786-93. PubMed ID: 17223922
[TBL] [Abstract][Full Text] [Related]
19. Localising prostate cancer: comparison of endorectal magnetic resonance (MR) imaging and 3D-MR spectroscopic imaging with transrectal ultrasound-guided biopsy.
Goris Gbenou MC; Peltier A; Addla SK; Lemort M; Bollens R; Larsimont D; Roumeguère T; Schulman CC; van Velthoven R
Urol Int; 2012; 88(1):12-7. PubMed ID: 22004874
[TBL] [Abstract][Full Text] [Related]
20. Staging of prostate cancer with endorectal MR imaging: lessons from a learning curve.
Harris RD; Schned AR; Heaney JA
Radiographics; 1995 Jul; 15(4):813-29; discussion 829-32. PubMed ID: 7569131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
